This site will be regularly updated with news about the upcoming Canadian choroideremia gene therapy clinical trial. For more information about our trial, click FAQs About Our Clinical Trial.
Comments and suggestions for this website are welcome!
Search for a term…
Author Archives: eyeuser
Our research team here at the University of Alberta, located in Edmonton, is one of a number of sites in North America and Europe currently working on a Natural History of Disease Study in choroideremia patients (called the NIGHT study … Continue reading
There has been a lot of activity in our research lab these past few months with the start of our clinical trial and with our summer students being around. We are excited to share some of the work with you! … Continue reading
We are excited to announce that our experimental gene therapy trial to treat choroideremia has began. Here is the official news release. This could not have been possible for our team without the involvement of our funding partners and our patients, … Continue reading
Hello everyone! Here is a long overdue update! After plenty of hard work from both parties, the University of Alberta and NightstaRx have been able to finalize the research agreement necessary for this clinical trial to take place. The brand … Continue reading
We have now received our final No Objection Letter from Health Canada! Our group has been actively working with NightStaRx Ltd. on finalizing the research agreement between this new biopharmaceutical company and the University of Alberta. This legal document will … Continue reading
As a recap of the year so far, our team at the University of Alberta has been hard at work preparing for our upcoming choroideremia gene therapy clinical trial. The study details, including the criteria for participation can be found here. … Continue reading
Many members of our research team had the opportunity to attend the 2nd International Scientific Symposium for Choroideremia in Denver, Colorado in June 2014. This well-received 2-day symposium was organized by the Choroideremia Research Foundation for experts in many different … Continue reading
Happy New Year! We are looking forward to 2014 and all that it will bring. We finished off 2013 on a high note: receiving our No Objection Letter (NOL) from Health Canada! This of course, means we have regulatory approval … Continue reading
Hi Everyone! We are all getting very excited about the upcoming trial this fall! In the last few months, we have had a pre-Clinical Trial Application (CTA) submission meeting with Health Canada and have since submitted our CTA. Now we … Continue reading
28 March 2013. The Alberta Ocular Gene Therapy Team has been successful in securing $5 Million over 5 years from Alberta Innovates – Health Solutions. The Team, based at the University of Alberta, is led by Dr. Ian MacDonald, Chair … Continue reading